Zai Lab Ltd $ 157.27 -4.41 (-2.73%)
Volume:
314,515
Avg Vol (1m):
370,454
Market Cap $:
13.83 Bil
Enterprise Value $:
13.39 Bil
PE Ratio:
0.00
PB Ratio:
24.29
Financial Strength | 4/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 24.57 | ||
| Debt-to-Equity | 0.04 | ||
| Debt-to-EBITDA | -0.11 | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 101.97 | ||
| Beneish M-Score | 62.17 | ||
| WACC vs ROIC | |||
Profitability Rank | 1/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -1896.78 | ||
| Net Margin % | -1807.08 | ||
| ROE % | -50.4 | ||
| ROA % | -42.96 | ||
| ROC (Joel Greenblatt) % | -557.57 | ||
| 3-Year EBITDA Growth Rate | -80.5 | ||
| 3-Year EPS without NRI Growth Rate | -58.8 |
ZLAB
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 24.29 | ||
| PS Ratio | 1044.82 | ||
| EV-to-EBIT | -75.33 | ||
| EV-to-EBITDA | -76.48 | ||
| EV-to-Revenue | 1355.39 | ||
| Current Ratio | 8.57 | ||
| Quick Ratio | 8.46 | ||
| Days Inventory | 339.72 | ||
| Days Sales Outstanding | 262.1 | ||
| Days Payable | 4027.49 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 2.5 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 24.76 | ||
| Earnings Yield (Greenblatt) % | -1.33 |